Drug and Medication Analysis & Statistics in Europe Countries, June 2013

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

1-50 of about 1 500 reports
Italy Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • June 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We projection deteriorating prospects for drugmakers in Italy because in addition to a decline in public spending on pharmaceuticals (enforced by price cuts ...

  • Industries : Drug and Medication
  • Countries : Italy
Poland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Poland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite numerous challenges, we continue to believe Poland is the most attractive pharmaceutical industry in Central and Eastern Europe (CEE). While the long-awaited ...

  • Industries : Drug and Medication
  • Countries : Poland
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 088
  • Industry report
  • May 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We stand by our negative projection for the Croatian pharmaceutical industry in 2012, on the back of the weakening economy and wide-ranging cost-containment ...

  • Industries : Drug and Medication
  • Countries : Croatia
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We continue to believe the Belarusian pharmaceutical industry has long-term potential due to the country's favourable geographic position, demographic profile ...

  • Industries : Drug and Medication
  • Countries : Belarus
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the strength of the UK's pharmaceutical manufacturing market is significant, the segment will face considerable challenges over the coming years. Economic ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Moldova's pharmaceutical industry recorded stronger growth in 2011, but its small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination fo ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Belgium, much like most of the other regional industries, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical revenues because ...

  • Industries : Drug and Medication
  • Countries : Belgium
Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • April 2013
  • by Business Monitor International

BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Germany
Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation ...

  • Industries : Drug and Medication
  • Countries : Greece
Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

BMI View: While we continue to see huge potential in the Ukrainian pharmaceutical industry, we are pessimistic with regard to short- and medium-term stability in the industry place. In particular, we ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Finland Pharmaceuticals and Healthcare Report Q2 2013

Finland Pharmaceuticals and Healthcare Report Q2 2013

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While Finland's pharmaceutical market is small compared with its Western European neighbours, BMI believes the country's high public expenditure on health and ...

  • Industries : Drug and Medication
  • Countries : Finland
Netherlands Business Projection Industry Update Quarter 2 2012

Netherlands Business Projection Industry Update Quarter 2 2012

  • $ 1 050
  • Industry report
  • April 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates Core Views The Dutch economy's growth outlook is set to seriously deteriorate in the coming quarters, as the eurozone sovereign debt crisis massively weighs on economic ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

BMI View: Sweden's high public expenditure on health (SEK252bn, or US Dollar 39bn, in 2011), accounting for 79% of total healthcare expenditure) is a major factor in making it an attractive place to sell ...

  • Industries : Drug and Medication
  • Countries : Sweden
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical industry, representing moderately good news for drugmakers. However, this development will ...

  • Industries : Drug and Medication
  • Countries : Hungary
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • March 2013
  • by Business Monitor International

BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical industry performed strongly in first nine months of 2011, which has led to upward revisions to our outlook for 2011 and ...

  • Industries : Drug and Medication
  • Countries : Latvia
Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: The pharmaceuticals and healthcare segment will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights ...

  • Industries : Drug and Medication
  • Countries : Italy
Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft ...

  • Industries : Drug and Medication
  • Countries : Romania
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all segments - including the pharmaceutical and healthcare market . Following ...

  • Industries : Drug and Medication
  • Countries : Portugal
Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 088
  • Industry report
  • February 2013
  • by Business Monitor International

BMI View: We believe the Spanish government's austerity measures are a necessary and prudent course of action. The country still has the third highest budget deficit in the eurozone and continues to receive ...

  • Industries : Drug and Medication
  • Countries : Spain
The Pharmaceutical Market: Serbia, Business Monitor International

The Pharmaceutical Market: Serbia, Business Monitor International

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN SERBIA While the market is small in terms of absolute numbers, relative per capita ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
The Pharmaceutical Market: Ukraine, Business Monitor International

The Pharmaceutical Market: Ukraine, Business Monitor International

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN UKRAINE Foreign and domestic drugmakers in Ukraine will see their operating margins ...

  • Industries : Drug and Medication
  • Countries : Ukraine
The Pharmaceutical Market: Netherlands, Business Monitor International

The Pharmaceutical Market: Netherlands, Business Monitor International

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE NETHERLANDS While the Netherlands is a low-risk market from the point of view ...

  • Industries : Drug and Medication
  • Countries : Netherlands
The Pharmaceutical Market: Slovakia, Business Monitor International

The Pharmaceutical Market: Slovakia, Business Monitor International

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN SLOVAKIA Slovak Prime Minister Robert Fico plans to unify the country'sprivate and ...

  • Industries : Drug and Medication
  • Countries : Slovakia (slovak Republic)
The Pharmaceutical Market: United Kindom

The Pharmaceutical Market: United Kindom

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED KINGDOM Drugmakers and governments will increasingly enter agreements that ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
The Pharmaceutical Market: Croatia, Business Monitor International

The Pharmaceutical Market: Croatia, Business Monitor International

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN CROATIA The Croatian pharmaceutical market continues to pose a challenging environment ...

  • Industries : Drug and Medication
  • Countries : Croatia
The Pharmaceutical Market: Italy, Business Monitor International

The Pharmaceutical Market: Italy, Business Monitor International

  • $ 1 266
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN ITALY The sharp drop in public pharmaceutical expenditure in Italy in the first fou ...

  • Industries : Drug and Medication
  • Countries : Italy

» Read our Company Profiles

2 Companies

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.